Greenway Greenhouse Cannabis Stock Net Income

GWAYF Stock   0.13  0.01  7.14%   
Fundamental analysis of Greenway Greenhouse allows traders to better anticipate movements in Greenway Greenhouse's stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Greenway Greenhouse Cannabis OTC Stock Net Income Analysis

Greenway Greenhouse's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Greenway Greenhouse Net Income

    
  (2.92 M)  
Most of Greenway Greenhouse's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenway Greenhouse Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Greenway Greenhouse Cannabis reported net income of (2.92 Million). This is 100.86% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers-Specialty & Generic industry. The net income for all United States stocks is 100.51% higher than that of the company.

Greenway Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenway Greenhouse's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Greenway Greenhouse could also be used in its relative valuation, which is a method of valuing Greenway Greenhouse by comparing valuation metrics of similar companies.
Greenway Greenhouse is currently under evaluation in net income category among its peers.

Greenway Fundamentals

About Greenway Greenhouse Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Greenway Greenhouse Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greenway Greenhouse using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greenway Greenhouse Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Greenway OTC Stock

Greenway Greenhouse financial ratios help investors to determine whether Greenway OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Greenway with respect to the benefits of owning Greenway Greenhouse security.